Gene expression of telomerase related proteins in human normal oral and ectocervical epithelial cells

Oral Oncology

Volumn 39, Issue 5, 2003, Pages 445-452

  Fujimoto, R ^a   Kamata, N ^a   Taki, M ^a   Yokoyama, K ^a   Tomonari, M ^a   Nagayama, M ^a   Yasumoto, S ^b  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b KANAGAWA CANCER CENTER   (Japan)

Author keywords

Aging; Alternate splicing; c Myc; hTERT; Normal oral keratinocytes; RT PCR; Telomerase; Telomeric repeat binding factor (TRF); TRAP assay

Indexed keywords

BINDING PROTEIN; ISOPROTEIN; MAX PROTEIN; MESSENGER RNA; MYC PROTEIN; PROTEIN MAD; RNA DIRECTED DNA POLYMERASE; TELOMERASE; TELOMERASE ASSOCIATED PROTEIN 1; TELOMERIC REPEAT BINDING FACTOR 1; TELOMERIC REPEAT BINDING FACTOR 2; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ARTICLE; CANCER CELL CULTURE; CELL AGING; CELL IMMORTALIZATION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; KERATINOCYTE; MOUTH MUCOSA; NORMAL HUMAN; PRIORITY JOURNAL; SIMIAN VIRUS 40; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX EPITHELIUM; VIRUS CULTURE; WART VIRUS;

EID: 0037566825     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(03)00003-4     Document Type: Article

References (42)

1. Greider C.W. Telomere length regulation. Annual Review of Biochemistry. 65:1996;337-365.
2. Kim N.W., Piatyszek M.A., Prowse K.R., Harley C.B., West M.D., Ho P.L.et al. Specific association of human telomerase activity with immortal cells and cancer. Science. 266:1994;2011-2015.
3. Meyerson M., Counter C.M., Eaton E.N., Ellisen L.W., Steiner P., Caddle S.D.et al. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell. 90:1997;785-795.
4. Nakamura T.M., Morin G.B., Chapman K.B., Weinrich S.L., Andrews W.H., Lingner J.et al. Telomerase catalytic subunit homologs from fission yeast and human. Science. 277:1997;955-959.
5. Nakayama J., Tahara H., Tahara E., Saito M., Ito K., Nakamura H.et al. Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat Genet. 18:1998;65-68.
6. Kilian A., Bowtell D.D., Abud H.E., Hime G.R., Venter D.J., Keese P.K.et al. Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Hum Mol Genet. 12:1997;2011-2019.
7. Ulaner G.A., Hu J.F., Vu T.H., Giudice L.C., Hoffman A.R. Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts. Cancer Res. 58:1998;4168-4172.
8. Wu K.J., Grandori C., Amacker M., Simon-Vermot N., Polack A., Lingner J.et al. Direct activation of TERT transcription by c-MYC. Nat Genet. 21:1999;220-224.
9. Greenberg R.A., O'Hagan R.C., Deng H., Xiao Q., Hann S.R., Adams R.R.et al. Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation. Oncogene. 18:1999;1219-1226.
10. Ayer D.E., Kretzner L., Eisenman R.N. Mad. a heterodimeric partner for Max that antagonizes Myc transcriptional activity Cell. 72:1993;211-222.
11. Zervos A.S., Gyuris J., Brent R. Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites. Cell. 72:1993;223-232.
12. Chong L., van Steensel B., Broccoli D., Erdjument-Bromage H., Hanish J., Tempst P.et al. A human telomeric protein. Science. 270:1995;1663-1667.
13. Broccoli D., Smogorzewska A., Chong L., de Lange T. Human telomeres contain two distinct Myb-related proteins, TRF1 and TRF2. Nat Genet. 17:1997;231-235.
14. Bilaud T., Brun C., Ancelin K., Koering C.E., Laroche T., Gilson E. Telomeric localization of TRF2, a novel human telobox protein. Nat Genet. 17:1997;236-239.
15. van Steensel B., de Lange T. Control of telomere length by the human telomeric protein TRF1. Nature. 385:1997;740-743.
16. Bianchi A., Smith S., Chong L., Elias P., de Lange T. TRF1 is a dimer and bends telomeric DNA. EMBO J. 16:1997;1785-1794.
17. Griffith J., Bianchi A., de Lange T. TRF1 promotes parallel pairing of telomeric tracts in vitro. J Mol Biol. 278:1998;79-88.
18. Griffith J.D., Comeau L., Rosenfield S., Stansel R.M., Bianchi A., Moss H.et al. Mammalian telomeres end in a large duplex loop. Cell. 97:1999;503-514.
19. van Steensel B., Smogorzewska A., de Lange T. TRF2 protects human telomeres from end-to-end fusions. Cell. 92:1998;401-413.
20. Karlseder J., Broccoli D., Dai Y., Hardy S., de Lange T. p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science. 283:1999;1321-1325.
21. Counter C.M., Hirte H.W., Bacchetti S., Harley C.B. Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci USA. 91:1994;2900-2904.
22. Counter C.M., Gupta J., Harley C.B., Leber B., Bacchetti S. Telomerase activity in normal leukocytes and in hematologic malignancies. Blood. 85:1995;2315-2320.
23. Harle-Bachor C., Boukamp P. Telomerase activity in the regenerative basal layer of the epidermis in human skin and immortal and carcinoma-derived skin keratinocytes. Proc Natl Acad Sci USA. 89:1996;10114-10118.
24. Yasumoto S., Kunimura C., Kikuchi K., Tahara H., Ohji H., Yamamoto H.et al. Telomerase activity in normal human epithelial cells. Oncogene. 13:1996;433-439.
25. Kunimura C., Kikuchi K., Ahmed N., Shimizu A., Yasumoto S. Telomerase activity in a specific cell subset co-expressing integrin beta1/EGFR but not p75NGFR/bcl2/integrin beta4 in normal human epithelial cells. Oncogene. 17:1998;187-197.
26. Kyo S., Takakura M., Kohama T., Inoue M. Telomerase activity in human endometrium. Cancer Res. 57:1997;610-614.
27. Sumida T., Hamakawa H., Sogawa K., Sugita A., Tanioka H., Ueda N. Telomerase component as a diagnostic tool in human oral lesions. Int J Cancer. 80:1999;801-804.
28. Kolquist K.A., Ellisen L.W., Counter C.M., Meyerson M., Tan L.K., Weinberg R.A.et al. Expression of TERT in early premalignant lesions and a subset of cells in normal tissue. Nat Genet. 19:1998;182-186.
29. Fujimoto R., Kamata N., Yokoyama K., Ueda N., Satomura K., Hayashi E.et al. Expression of telomerase components in oral keratinocytes and squamous cell carcinomas. Oral Oncol. 37:2001;132-140.
30. Apiwat M., Pakpoom S., Saengsoon T., Virote S., Anavaj S., Saowanee Y.et al. Telomerase activity in oral leukoplakia and head and neck squamous cell carcinoma. Cancer Res. 56:1996;3530-3533.
31. Miyoshi Y., Tsukinoki K., Imaizumi T., Yamada Y., Ishizaki K., Watanabe Y.et al. Telomerase activity in oral cancer. Oral Oncol. 35:1999;283-289.
32. Kamata N., Yokoyama K., Fujimoto R., Ueda N., Hayashi E., Nakanishi H.et al. Growth of normal oral keratinocytes and squamous cell carcinoma cells in a novel protein-free defined medium. In Vitro Cell Dev Biol Anim. 35:1999;635-641.
33. Yokoyama K., Kamata N., Hayashi E., Hoteiya T., Ueda N., Fujimoto R.et al. Reverse correlation of E-cadherin and snail expression in oral squamous cell carcinoma cells in vitro. Oral Oncol. 37:2001;65-71.
34. Yasumoto S., Taniguchi A., Sohma K. Epidermal growth factor (EGF) elicits down-regulation of human papillomavirus type 16 (HPV-16) E6/E7 mRNA at the transcriptional level in an EGF-stimulated human keratinocyte cell line. functional role of EGF-responsive silencer in the HPV-16 long control region J Virol. 65:1991;2000-2009.
35. Hashida T., Yasumoto S. Induction of chromosome abnormalities in mouse and human epidermal keratinocytes by the human papillomavirus type 16 E7 oncogene. J Gen Virol. 72:1991;1569-1577.
36. Pirisi L., Yasumoto S., Feller M., Doniger J., DiPaolo J.A. Transformation of human fibroblasts and keratinocytes with human papillomavirus type 16 DNA. J Virol. 61(4):1987;1061-1066.
37. Weinrich S.L., Pruzan R., Ma L., Ouellette M., Tesmer V.M., Holt S.E.et al. Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nat Genet. 17:1997;498-502.
38. Yi X., White D.M., Aisner D.L., Baur J.A., Wright W.E., Shay J.W. An alternate splicing variant of the human telomerase catalytic subunit inhibits telomerase activity. Neoplasia. 2:2000;433-440.
39. Suwa T., Yang L., Hornsby P.J. Telomerase activity in primary cultures of normal adrenocortical cells. J Endocrinol. 170:2001;677-684.
40. Yamada K., Yajima T., Yagihashi A., Kobayashi D., Koyanagi Y., Asanuma K.et al. Role of human telomerase reverse transcriptase and telomeric-repeat binding factor proteins 1 and 2 in human hematopoietic cells. Jpn J Cancer Res. 91:2000;1278-1284.
41. Karlseder J., Smogorzewska A., de Lange T. Senescence induced by altered telomere state, not telomere loss. Science. 295:2002;2446-2449.
42. Colgin L.M., Wilkinson C., Englezou A., Kilian A., Robinson M.O., Reddel R.R. The hTERT alpha splice variant is a dominant negative inhibitor of telomerase activity. Neoplasia. 2:2000;426-432.